Status:
COMPLETED
Ventricular and Pulmonary Vascular Reserve After the Fontan Operation
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Heart Failure
Congenital Heart Disease
Eligibility:
All Genders
18-99 years
Brief Summary
Aim #1: Define and determine the prevalence of pulmonary vascular disease and diastolic dysfunction as assessed by the gold standard of invasive hemodynamic cardiopulmonary exercise testing. Aim #2: ...
Detailed Description
Define and determine the prevalence of pulmonary vascular disease and diastolic dysfunction as assessed by the gold standard of invasive hemodynamic cardiopulmonary exercise testing. Subjects with Fon...
Eligibility Criteria
Inclusion
- Fontan Palliation
- Age ≥18 years
Exclusion
- No clinical indication for cardiac catheterization
Key Trial Info
Start Date :
August 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 21 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03853837
Start Date
August 30 2018
End Date
July 21 2022
Last Update
October 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905